Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 28Colorectal Neoplasms 13Colonic Neoplasms 13Rectal Neoplasms 9Prostatic Neoplasms 7Head and Neck Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Melanoma 5Endometrial Neoplasms 5Central Nervous System Neoplasms 5Ovarian Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Carcinoma, Ovarian Epithelial 4Pancreatic Neoplasms 3Neuroblastoma 3Liver Neoplasms 3Liposarcoma 3Hemangiosarcoma 3Hemangiopericytoma, Malignant 3Gallbladder Neoplasms 3Fibrosarcoma 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Hepatocellular 3

Interventions

Letrozole 5Clomiphene 4follitropin alfa 2Tamoxifen 2Metformin 2Goserelin 2Cyclophosphamide 2follitropin beta 1cetrorelix 1Urofollitropin 1Triptorelin Pamoate 1Thioctic Acid 1Therapeutics 1Surgical Procedures, Operative 1Sperm Injections, Intracytoplasmic 1Neoadjuvant Therapy 1Congresses as Topic 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Infertility × Chemotherapy, Adjuvant × Clear all
NCT00427245 2013-08-07

Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Completed
400 enrolled
Breast

Breast Neoplasms, Infertility

Data powered by HemOnc (CC BY 4.0) Colophon âš¡